---
reference_id: "PMID:24176425"
title: "Clinical neurogenetics: huntington disease."
authors:
- Bordelon YM
journal: Neurol Clin
year: '2013'
doi: 10.1016/j.ncl.2013.05.004
content_type: abstract_only
---

# Clinical neurogenetics: huntington disease.
**Authors:** Bordelon YM
**Journal:** Neurol Clin (2013)
**DOI:** [10.1016/j.ncl.2013.05.004](https://doi.org/10.1016/j.ncl.2013.05.004)

## Content

1. Neurol Clin. 2013 Nov;31(4):1085-94. doi: 10.1016/j.ncl.2013.05.004. Epub 2013
 Jul 18.

Clinical neurogenetics: huntington disease.

Bordelon YM(1).

Author information:
(1)Department of Neurology, David Geffen School of Medicine at UCLA, 710 
Westwood Plaza, Los Angeles, CA 90210, USA. Electronic address: 
ybordelon@mednet.ucla.edu.

Huntington disease (HD) is an autosomal dominant, adult-onset, progressive 
neurodegenerative disease characterized by the triad of abnormal movements 
(typically chorea), cognitive impairment, and psychiatric problems. It is caused 
by an expanded CAG repeat in the gene encoding the protein huntingtin on 
chromosome 4 and causes progressive atrophy of the striatum as well as cortical 
and other extrastriatal structures. Genetic testing has been available since 
1993 to confirm diagnosis in affected adults and for presymptomatic testing in 
at-risk individuals. This review covers HD signs, symptoms, and pathophysiology; 
current genetic testing issues; and current and future treatment strategies.

Copyright Â© 2013 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.ncl.2013.05.004
PMID: 24176425 [Indexed for MEDLINE]